athenahealth, Inc. (NASDAQ:ATHN)‘s stock had its “outperform” rating reaffirmed by equities researchers at Evercore ISI in a research report issued to clients and investors on Saturday. They presently have a $163.00 price target on the health services provider’s stock, up from their previous price target of $155.00. Evercore ISI’s price objective would indicate a potential upside of 4.53% from the company’s previous close.
A number of other research analysts have also issued reports on ATHN. UBS AG set a $123.00 price objective on athenahealth and gave the company a “buy” rating in a research report on Monday, May 1st. Wells Fargo & Company restated an “outperform” rating and set a $190.00 price objective (up previously from $130.00) on shares of athenahealth in a research report on Saturday. BidaskClub lowered athenahealth from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th. Oppenheimer Holdings, Inc. boosted their price objective on athenahealth from $154.00 to $184.00 and gave the company an “outperform” rating in a research report on Friday. Finally, Piper Jaffray Companies restated an “overweight” rating and set a $171.00 price objective on shares of athenahealth in a research report on Friday. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and twelve have issued a buy rating to the stock. athenahealth presently has a consensus rating of “Hold” and a consensus target price of $146.18.
athenahealth (NASDAQ ATHN) traded up 8.44% during midday trading on Friday, hitting $155.93. The stock had a trading volume of 2,286,356 shares. The firm has a market cap of $6.21 billion, a PE ratio of 306.95 and a beta of 1.79. The stock has a 50-day moving average price of $141.51 and a 200 day moving average price of $122.62. athenahealth has a one year low of $90.11 and a one year high of $158.66.
athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.39 by $0.12. athenahealth had a return on equity of 7.11% and a net margin of 2.80%. The business had revenue of $301.10 million during the quarter, compared to analyst estimates of $298.68 million. During the same quarter in the previous year, the firm posted $0.34 EPS. The business’s revenue for the quarter was up 15.0% compared to the same quarter last year. On average, analysts predict that athenahealth will post $1.86 earnings per share for the current year.
In other news, CFO Karl Stubelis sold 3,952 shares of the business’s stock in a transaction on Monday, June 5th. The stock was sold at an average price of $138.98, for a total transaction of $549,248.96. Following the sale, the chief financial officer now directly owns 21,810 shares of the company’s stock, valued at $3,031,153.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jonathan Bush sold 8,000 shares of the business’s stock in a transaction on Tuesday, April 25th. The stock was sold at an average price of $120.00, for a total value of $960,000.00. Following the sale, the chief executive officer now directly owns 319,807 shares in the company, valued at $38,376,840. The disclosure for this sale can be found here. Insiders have sold 26,105 shares of company stock worth $3,394,859 over the last ninety days. 3.20% of the stock is owned by insiders.
Several large investors have recently made changes to their positions in ATHN. Comerica Bank raised its stake in shares of athenahealth by 0.6% in the first quarter. Comerica Bank now owns 2,487 shares of the health services provider’s stock worth $302,000 after buying an additional 14 shares during the period. Fairfield Bush & CO. raised its stake in shares of athenahealth by 0.7% in the first quarter. Fairfield Bush & CO. now owns 4,923 shares of the health services provider’s stock worth $555,000 after buying an additional 35 shares during the period. Bell Bank raised its stake in shares of athenahealth by 2.6% in the first quarter. Bell Bank now owns 3,600 shares of the health services provider’s stock worth $406,000 after buying an additional 90 shares during the period. Baird Financial Group Inc. raised its stake in shares of athenahealth by 0.9% in the first quarter. Baird Financial Group Inc. now owns 11,818 shares of the health services provider’s stock worth $1,332,000 after buying an additional 105 shares during the period. Finally, US Bancorp DE raised its stake in shares of athenahealth by 0.6% in the first quarter. US Bancorp DE now owns 19,864 shares of the health services provider’s stock worth $2,238,000 after buying an additional 123 shares during the period.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
